Variants assigned to the “insulin action” and “dyslipidemia” clusters corresponded to signals with significantly higher adipose (1.5-fold, p = 0.034) and liver scores (2.9-fold, p = 0.009), respectively (Figures 3F and 3G). The gene discussed is INS; the disease is metabolic syndrome.